Cannabis and the Workplace: Legalization Outpaced the Research on Safety, Impairment, and Testing

This commentary from researchers at NIOSH (the federal workplace safety agency) identified a fundamental gap: cannabis legalization was reshaping the American workforce, but almost no research existed to guide workplace policy. Past policies were built when cannabis was universally illegal and any use was considered problematic. That framework no longer applied in states with legal access.

The authors identified several urgent research needs: which industries and occupations had the highest cannabis use, what the actual safety risks were for impaired workers, whether different cannabis products carried different workplace risks, and how to test for current impairment rather than past use.

The last point was particularly critical. Standard urine drug testing detects THC metabolites for days or weeks after use, making it a test of recent history rather than current impairment. For a legal substance, that's like testing employees for whether they drank alcohol last weekend rather than whether they're drunk at work.

This paper matters because of who wrote it. NIOSH is the federal agency responsible for workplace safety research. When they publish that existing cannabis workplace policies aren't grounded in evidence, it signals that the entire framework needs rebuilding.

The drug testing issue is the most immediately consequential. Millions of American workers are subject to cannabis testing that can't distinguish between someone who used cannabis three weeks ago on vacation and someone who is impaired at work right now. For a substance that's legal in most states, that's an increasingly untenable position — and the research to develop better impairment testing hadn't been done.